1. Home
  2. BMRN vs MOS Comparison

BMRN vs MOS Comparison

Compare BMRN & MOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • MOS
  • Stock Information
  • Founded
  • BMRN 1996
  • MOS 1987
  • Country
  • BMRN United States
  • MOS United States
  • Employees
  • BMRN N/A
  • MOS N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • MOS Agricultural Chemicals
  • Sector
  • BMRN Health Care
  • MOS Industrials
  • Exchange
  • BMRN Nasdaq
  • MOS Nasdaq
  • Market Cap
  • BMRN 10.0B
  • MOS 10.6B
  • IPO Year
  • BMRN 1999
  • MOS 2004
  • Fundamental
  • Price
  • BMRN $51.66
  • MOS $25.04
  • Analyst Decision
  • BMRN Buy
  • MOS Buy
  • Analyst Count
  • BMRN 19
  • MOS 14
  • Target Price
  • BMRN $90.26
  • MOS $36.43
  • AVG Volume (30 Days)
  • BMRN 2.8M
  • MOS 6.5M
  • Earning Date
  • BMRN 10-27-2025
  • MOS 11-04-2025
  • Dividend Yield
  • BMRN N/A
  • MOS 3.51%
  • EPS Growth
  • BMRN 59.53
  • MOS 236.10
  • EPS
  • BMRN 2.68
  • MOS 3.87
  • Revenue
  • BMRN $3,094,001,000.00
  • MOS $11,894,600,000.00
  • Revenue This Year
  • BMRN $13.32
  • MOS $16.57
  • Revenue Next Year
  • BMRN $7.51
  • MOS $1.03
  • P/E Ratio
  • BMRN $19.34
  • MOS $6.49
  • Revenue Growth
  • BMRN 12.39
  • MOS 3.83
  • 52 Week Low
  • BMRN $51.00
  • MOS $22.36
  • 52 Week High
  • BMRN $73.51
  • MOS $38.23
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 41.11
  • MOS 18.16
  • Support Level
  • BMRN $51.80
  • MOS $28.92
  • Resistance Level
  • BMRN $53.49
  • MOS $27.85
  • Average True Range (ATR)
  • BMRN 1.85
  • MOS 0.87
  • MACD
  • BMRN -0.04
  • MOS -0.31
  • Stochastic Oscillator
  • BMRN 11.07
  • MOS 1.50

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About MOS Mosaic Company (The)

Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in Florida, Brazil, and Peru and potash mines in Saskatchewan, New Mexico, and Brazil. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosaic Fertilizantes business.

Share on Social Networks: